Brief: Active Biotech Acquires Rights To Patents Of Tasquinimod In Combination Therapy
May 22 (Reuters) - Active Biotech AB publ ACTI.ST :
* ACQUIRES EXCLUSIVE RIGHTS TO PATENTS OF TASQUINIMOD IN COMBINATION THERAPY
* EXCLUSIVE LICENSE AGREEMENT WITH WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
Source text for Eikon: ID:nMFN55R2hh
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million